|
2026 Journal Article Large-scale testing of antimicrobial lethality at single-cell resolution predicts mycobacterial infection outcomesJovanovic, Alexander, Bright, Frederick K., Sadeghi, Ahmad, Wicki, Basil, Caño Muñiz, Santiago E., Giannini, Greta C., Toprak, Sara, Sauteur, Loïc, Rodoni, Anna, Wüst, Andreas, Lupien, Andréanne, Borrell, Sonia, Grogono, Dorothy M., Wheeler, Nicole E., Dehio, Philippe, Nemeth, Johannes, Pargger, Hans, Thomson, Rachel, Bell, Scott C., Gagneux, Sebastien, Bryant, Josephine M., Peng, Tingying, Diacon, Andreas H., Floto, R. Andres, Abanto, Michael and Boeck, Lucas (2026). Large-scale testing of antimicrobial lethality at single-cell resolution predicts mycobacterial infection outcomes. Nature Microbiology. doi: 10.1038/s41564-025-02217-y |
|
2025 Journal Article Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guardEvans, Ieuan Edward Shepherd, Smith, Daniel, Henderson, Daniel, Riddles, Timothy, Masel, Philip, Moore, Vanessa, Burke, Andrew J., Thomson, Rachel M. and Reid, David W. (2025). Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guard. BMJ Open Respiratory Research, 12 (1) e003204, e003204. doi: 10.1136/bmjresp-2025-003204 |
|
2025 Journal Article In vitro efficacy of sulbactam/durlobactam combined with β-lactam antibiotics in Australian Mycobacterium abscessus isolatesPatterson-Fahy, Kirby, Carter, Robyn, Bell, Scott C., Evans, Ieuan E. S., Burke, Andrew John and Thomson, Rachel M. (2025). In vitro efficacy of sulbactam/durlobactam combined with β-lactam antibiotics in Australian Mycobacterium abscessus isolates. Journal of Antimicrobial Chemotherapy, 81 (1) dkaf441, 1-9. doi: 10.1093/jac/dkaf441 |
|
2025 Journal Article Consensus on Management of Refractory Nontuberculous Mycobacterial Pulmonary DiseaseMoreira-Sousa, Diana, Martins, Beatriz, Aguiar, Ana, Pinheiro, Marina, Akkerman, Onno, Aksamit, Timothy R, Aliberti, Stefano, Andrejak, Claire, Daley, Charles L., van Ingen, Jakko, Lange, Christoph, Lipman, Marc, Loebinger, Michael R, Jankovic Makek, Mateja, Morimoto, Kozo, Thomson, Rachel M., Wagner, Dirk, Winthrop, Kevin L., Yim, Jae-Joon and Duarte, Raquel (2025). Consensus on Management of Refractory Nontuberculous Mycobacterial Pulmonary Disease. European Respiratory Journal, 67 (1), 2500400. doi: 10.1183/13993003.00400-2025 |
|
2025 Journal Article The microbiome and gut–lung axis in nontuberculous mycobacterial pulmonary diseaseThompson, Ria N., Blumenthal, Antje, Morrison, Mark and Thomson, Rachel M. (2025). The microbiome and gut–lung axis in nontuberculous mycobacterial pulmonary disease. PLOS Pathogens, 21 (10) e1013603, e1013603. doi: 10.1371/journal.ppat.1013603 |
|
2025 Journal Article Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trialJong, Tiffany, Baird, Timothy, Barr, Helen Louise, Bell, Scott, Bigirumurame, Theophile, Brady, Kara, Burke, Andrew, Byrnes, Joshua, Caudri, Daan, Clark, Julia E., Coin, Lachlan J.M., Goh, Felicia, Grimwood, Keith, Hicks, Daniel, Jayawardana, Kaushala, Joshi, Sri, Lee, Katherine, Qvist, Tavs, Reid, David, Rice, Megan, Roberts, Jason A., Rogers, Geraint, Shackleton, Claire, Sly, Peter D., Smyth, Alan R., Stevens, Luke, Stockwell, Rebecca, Tarique, Abdullah, Taylor, Steven ... Wainwright, Claire (2025). Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial. BMJ Open, 15 (9) e096188, 1-16. doi: 10.1136/bmjopen-2024-096188 |
|
2025 Journal Article The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studiesEvans, Ieuan ES, Duplancic, Christine M, Kidd, Timothy A, Ballard, Emma L, Thomson, Rachel M, Wainwright, Claire E and Bell, Scott C (2025). The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies. Journal of Cystic Fibrosis, 24 (5), 903-908. doi: 10.1016/j.jcf.2025.07.002 |
|
2025 Journal Article Disinfectant and antibiotic resistance in Mycobacterium abscessus water isolatesPatterson-Fahy, Kirby, Carter, Robyn, Taylor, Steven L., Guo, Jianhua and Thomson, Rachel M. (2025). Disinfectant and antibiotic resistance in Mycobacterium abscessus water isolates. Microbiology Spectrum, 13 (7) e0337424, 1-12. doi: 10.1128/spectrum.03374-24 |
|
2025 Journal Article World Bronchiectasis 2025—Inclusive Lungs, Diverse SolutionsThomson, Rachel Mary and Morgan, Lucy Catriona (2025). World Bronchiectasis 2025—Inclusive Lungs, Diverse Solutions. Respirology, 30 (7), 552-554. doi: 10.1111/resp.70063 |
|
2025 Journal Article A pilot study to assess the effect of intermittent inhaled nitric oxide as treatment of nontuberculous mycobacteria lung infectionThomson, Rachel M., Burke, Andrew J., Morgan, Lucy C. and Colin, Andrew A. (2025). A pilot study to assess the effect of intermittent inhaled nitric oxide as treatment of nontuberculous mycobacteria lung infection. Annals of the American Thoracic Society, 22 (7), 1092-1097. doi: 10.1513/annalsats.202407-745rl |
|
2025 Journal Article Infection by clonally related Mycobacterium abscessus isolates: the role of drinking waterThomson, Rachel M., Wheeler, Nicole, Stockwell, Rebecca E., Bryant, Josephine, Taylor, Steven L, Leong, Lex E. X., Le, Trieu, Rogers, Geraint B, Carter, Robyn, Sherrard, Laura J, Powell, Harry, Simpson, Graham, Patterson-Fahy, Kirby, Wainwright, Claire E., Floto, R. Andres, Parkhill, Julian and Bell, Scott C. (2025). Infection by clonally related Mycobacterium abscessus isolates: the role of drinking water. American Journal of Respiratory and Critical Care Medicine, 211 (5), 842-853. doi: 10.1164/rccm.202409-1824oc |
|
2025 Journal Article Pediatric physiotherapy management of airway clearance therapy and exercise: data from the Australian Bronchiectasis RegistryWebb, Elizabeth M., Holland, Anne E., Chang, Anne B., Middleton, Peter G., Thomson, Rachel, Wong, Conroy, Jayaram, Lata, Holmes‐Liew, Chien‐Li, Morgan, Lucy and Lee, Annemarie L. (2025). Pediatric physiotherapy management of airway clearance therapy and exercise: data from the Australian Bronchiectasis Registry. Pediatric Pulmonology, 60 (1) e27370, 1-9. doi: 10.1002/ppul.27370 |
|
2024 Journal Article Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis RegistryWebb, Elizabeth M., Holland, Anne E., Chang, Anne B., Burr, Lucy, Holmes-Liew, Chien-Li, King, Paul T., Middleton, Peter G., Morgan, Lucy, Thomson, Rachel M., Wong, Conroy and Lee, Annemarie L. (2024). Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis Registry. Respiratory Medicine, 233 107777, 1-8. doi: 10.1016/j.rmed.2024.107777 |
|
2024 Journal Article Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 monthsHaworth, Charles S., Shteinberg, Michal, Winthrop, Kevin, Barker, Alan, Blasi, Francesco, Dimakou, Katerina, Morgan, Lucy C., O'Donnell, Anne E., Ringshausen, Felix C., Sibila, Oriol, Thomson, Rachel M., Carroll, Kevin J., Pontenani, Federica, Castellani, Paola, Chalmers, James and PROMIS Trial Investigators, (2024). Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months. Lancet Respiratory Medicine, 12 (10), 787-798. doi: 10.1016/-2600(24)00225-X |
|
2024 Journal Article OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infectionThomson, Rachel M., Loebinger, Michael R., Burke, Andrew J., Morgan, Lucy C., Waterer, Grant W. and Ganslandt, Cecilia (2024). OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infection. Annals of the American Thoracic Society, 21 (4), 568-576. doi: 10.1513/annalsats.202306-532oc |
|
2023 Journal Article Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogensHuang, Casey K., Weerasekara, Anjani, Lu, Ji, Carter, Robyn, Weynberg, Karen D., Thomson, Rachel, Bell, Scott and Guo, Jianhua (2023). Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens. Water Research: X, 21 100201, 100201. doi: 10.1016/j.wroa.2023.100201 |
|
2023 Journal Article Things They Are a Changing in the Field of Nontuberculous MycobacteriaKasperbauer, Shannon and Thomson, Rachel (2023). Things They Are a Changing in the Field of Nontuberculous Mycobacteria. Clinics in Chest Medicine, 44 (4), xiii-xiv. doi: 10.1016/j.ccm.2023.09.001 |
|
2023 Journal Article In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolatesBurke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938 |
|
2023 Journal Article A systematic review of the clinical impact of small colony variants in patients with cystic fibrosisRyan, Harrigan, Ballard, Emma, Stockwell, Rebecca E., Duplancic, Christine, Thomson, Rachel M., Smith, Kimberley and Bell, Scott C. (2023). A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis. BMC Pulmonary Medicine, 23 (1) 323, 1-10. doi: 10.1186/s12890-023-02611-4 |
|
2023 Journal Article Environmental risk of nontuberculous mycobacterial infection: strategies for advancing methodologyMercaldo, Rachel A., Marshall, Julia E., Cangelosi, Gerard A., Donohue, Maura, Falkinham, Joseph O., Fierer, Noah, French, Joshua P., Gebert, Matthew J., Honda, Jennifer R., Lipner, Ettie M., Marras, Theodore K., Morimoto, Kozo, Salfinger, Max, Stout, Janet, Thomson, Rachel and Prevots, D. Rebecca (2023). Environmental risk of nontuberculous mycobacterial infection: strategies for advancing methodology. Tuberculosis, 139 102305, 102305. doi: 10.1016/j.tube.2023.102305 |
